“The Efficacy of Certolizumab Pegol Re-Treatment on Plaque Psoriasis Following a Blinded Treatment Break: Results from the CIMPACT Trial”, J of Skin, vol. 3, no. 2, p. 174, Mar. 2019, doi: 10.25251/skin.3.2.14.